Back
Cleveland-Cliffs Vs. Dyne Therapeutics Industry Stock Comparison
Sell
42
CLF
Cleveland-Cliffs
Last Price:
15.01
Seasonality Move:
1.51%
Buy
64
DYN
Dyne Therapeutics
Last Price:
35.41
Seasonality Move:
29.58%
Sell
42
Cleveland-Cliffs (CLF)
is a Sell
Is Cleveland-Cliffs a Buy, Sell or Hold?
- The current Cleveland-Cliffs [CLF] share price is $14.93. The Score for CLF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- CLF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $33.92. The Score for DYN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CLF Stock Price Chart
What is Cleveland-Cliffs's stock price today?
-
The Cleveland-Cliffs share price today is $14.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLF is experiencing buying pressure, which is a positive indicator for future bullish movement.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $33.92
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DYN is experiencing buying pressure, which is a positive indicator for future bullish movement.
CLF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.77 | Sell |
Relative Strength Index (14 RSI): | 33.38 | Sell |
Chaikin Money Flow: | 11879437 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.85 - 16.89) | Sell |
Bollinger Bands (100): | (16.6 - 21.28) | Sell |
DYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.3 | Buy |
Relative Strength Index (14 RSI): | 57.37 | Buy |
Chaikin Money Flow: | 599904 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.98 - 33.66) | Buy |
Bollinger Bands (100): | (23.98 - 30.96) | Buy |
CLF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.76 | Buy |
20-day SMA: | 15.56 | Sell |
50-day SMA: | 17.08 | Sell |
200-day SMA: | 18.02 | Sell |
8-day EMA: | 14.86 | Buy |
20-day EMA: | 15.49 | Sell |
50-day EMA: | 16.88 | Sell |
200-day EMA: | 17.98 | Sell |
DYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.61 | Buy |
20-day SMA: | 32.56 | Buy |
50-day SMA: | 29.25 | Buy |
200-day SMA: | 19.48 | Buy |
8-day EMA: | 33.72 | Buy |
20-day EMA: | 32.57 | Buy |
50-day EMA: | 30.2 | Buy |
200-day EMA: | 22.36 | Buy |
Cleveland-Cliffs Earnings Growth & CLF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.40 per share, an increase next quarter of $0.24 per share, a decrease this year of $0.51 per share, and an increase next year of $0.78 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.77 per share, and an increase next year of $0.16 per share.
Cleveland-Cliffs Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dyne Therapeutics Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |